+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eribulin"

Eribulin Market Insights 2019, Analysis and Forecast Global and Chinese Market to 2024, by Manufacturers, Product Type, Application, Regions and Technology - Product Thumbnail Image

Eribulin Market Insights 2019, Analysis and Forecast Global and Chinese Market to 2024, by Manufacturers, Product Type, Application, Regions and Technology

  • Report
  • 142 Pages
From
Global and Chinese Eribulin Industry - 2018 - Product Thumbnail Image

Global and Chinese Eribulin Industry - 2018

  • Report
  • 143 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

  • Report
  • 215 Pages
From
Global Breast Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025 - Product Thumbnail Image

Global Breast Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025

  • Report
From
US Breast Cancer Drug Market Outlook 2022 - Product Thumbnail Image

US Breast Cancer Drug Market Outlook 2022

  • Report
  • 130 Pages
From
US Breast Cancer Therapy Market Opportunity Analysis - Product Thumbnail Image

US Breast Cancer Therapy Market Opportunity Analysis

  • Report
  • 700 Pages
From
Breast Cancer: Triple - Negative: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Breast Cancer: Triple - Negative: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 290 Pages
From
Hormone Receptor (HR)-Positive/Human Epidermal Receptor 2 (HER2)- Negative Breast Cancer- Market Insights, Epidemiology and Market Forecast - 2028 - Product Thumbnail Image

Hormone Receptor (HR)-Positive/Human Epidermal Receptor 2 (HER2)- Negative Breast Cancer- Market Insights, Epidemiology and Market Forecast - 2028

  • Drug Pipelines
  • 360 Pages
From
Breast Cancer: Hr+/Her2-: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Breast Cancer: Hr+/Her2-: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 273 Pages
From
PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2025 - Product Thumbnail Image

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2025

  • Report
  • 416 Pages
From
  • 10 Results (Page 1 of 1)
Loading Indicator
adroll